Harmony Biosciences Announces Date of Third Quarter 2021 Financial Results

PLYMOUTH MEETING, Pa., Oct. 26, 2021 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony” or the “Company”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.